Tocilizumab use for the treatment of COVID-19 in pregnancy
Researchers from Mount Sinai Hospital, Toronto, Canada have published a narrative review of tocilizumab use for the treatment of COVID-19 in pregnancy. They located data describing 610 tocilizumab-exposed pregnancies, with 20 receiving treatment due to severe COVID-19. This review may be helpful for those providing counselling on the safety of COVID-19 treatments in pregnancy. More information can be found here.